The Mid Yorkshire Hospitals NHS Trust has received a generous donation of £40,000 from the Dr Jackson Cancer fund, to purchase a Robotic Ultrasound Probe, which will help to identify cancerous tumours in more detail during surgery.
The new device will be used in surgery during Robotic Partial Nephrectomy to aid the imaging of kidney tumours. Robotic Partial Nephrectomy is a kidney-sparing surgery where the tumour is removed from the kidney leaving healthy kidney tissue in place to maintain the kidney function.
Mr Muhammad Elmussareh, Consultant Urologist at The Mid Yorkshire Hospitals NHS Trust said: “We are extremely grateful to the Dr Jackson Cancer Fund for their continued support of our Cancer services here at Mid Yorks, which is vital in supporting our aim of providing excellent cancer care. The provision of this cutting edge new device will ensure that when we remove tumours from the kidney we will be able to leave more tissue in place to maintain the kidney function as much as possible.”
The Dr Jackson Cancer Fund, based in Pontefract, promotes research into the treatment and prevention of cancer, and finances the introduction of successful new techniques.
Sir William O’Brien, Chair of Trustees of the Dr Jackson Cancer Fund, said; “We are very pleased to be able to fund this new device for the cancer surgery team at The Mid Yorkshire Hospitals NHS Trust and hope many patients will benefit from this state of the art technology. We are proud to support the Cancer team and hope to do so more in the future.”